{"name": "Cell Therapeutics",
 "permalink": "cell-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/cell-therapeutics",
 "homepage_url": "http://www.celltherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1991,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "206-282-7100",
 "description": "",
 "created_at": "Sat Jan 16 05:01:02 UTC 2010",
 "updated_at": "Fri Apr 20 03:44:22 UTC 2012",
 "overview": "\u003Cp\u003ECell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkin\u00e2\u20ac\u2122s lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers. It has collaboration and licensing arrangements with Novartis International Pharmaceutical, Ltd.; and PG-TXL Company, L.P. The company was founded in 1991 and is headquartered in Seattle, Washington.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[125,
       47],
      "assets/images/resized/0007/3669/73669v1-max-150x150.png"],
     [[125,
       47],
      "assets/images/resized/0007/3669/73669v1-max-250x250.png"],
     [[125,
       47],
      "assets/images/resized/0007/3669/73669v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "James",
      "last_name": "A. Bianco",
      "permalink": "james-a-bianco",
      "image": null}},
   {"is_past": false,
    "title": "EVP, Finance and Administration",
    "person":
     {"first_name": "Louis",
      "last_name": "A. Bianco",
      "permalink": "louis-a-bianco",
      "image": null}},
   {"is_past": true,
    "title": "VP, Acquisitions",
    "person":
     {"first_name": "Kathleen",
      "last_name": "Fanning",
      "permalink": "kathleen-fanning",
      "image": null}},
   {"is_past": true,
    "title": "Vice President, Regulatory Affairs and Quality Assurance",
    "person":
     {"first_name": "Allene",
      "last_name": "Dodge",
      "permalink": "allene-dodge",
      "image": null}},
   {"is_past": true,
    "title": "Scientist",
    "person":
     {"first_name": "Donna",
      "last_name": "Matuizek",
      "permalink": "donna-matuizek",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$76M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/cell-therapeutics-stock-sale-raises-30m-and-eyebrows/2010-01-15?utm_medium=rss\u0026utm_source=rss\u0026cmp-id=OTC-RSS-FB0",
    "source_description": "Cell Therapeutics stock sale raises $30M and eyebrows",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 8,
    "funded_day": 19,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/struggling-cell-therapeutics-raises-21m-stock-sale/2010-05-24?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Struggling Cell Therapeutics raises $21M in stock sale",
    "raised_amount": 21000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 5,
    "funded_day": 24,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/cell-therapeutics-raises-25m/2011-01-13?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Cell Therapeutics raises $25M",
    "raised_amount": 25000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 13,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "501 Elliott Ave. W. #400",
    "address2": "",
    "zip_code": "98119",
    "city": "Seattle",
    "state_code": "WA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "UPDATED: Cell Therapeutics lands myelofibrosis drug with $30M upfront",
    "stoned_year": 2012,
    "stoned_month": 4,
    "stoned_day": 19,
    "source_url": "http://www.fiercebiotech.com/story/cell-therapeutics-lands-myelofibrosis-drug-30m-upfront/2012-04-19",
    "source_text": "",
    "source_description": "UPDATED: Cell Therapeutics lands myelofibrosis drug with $30M upfront",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cell Therapeutics",
      "permalink": "cell-therapeutics"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:CTIC"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/3668/73668v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/3668/73668v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/3668/73668v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}